Skip to main content

Advertisement

Table 4 Sensitivity analyses on risks of mortality among TCM usersa

From: Traditional Chinese medicine use is associated with lower end-stage renal disease and mortality rates among patients with diabetic nephropathy: a population-based cohort study

Model aHR (95% CI)a Sig.
Full cohort (n = 121,739)b 0.49 (0.48–0.50) ***
Same study cohort with inverse probability weighting (n = 107,294) 0.51 (0.49–0.52) ***
Redefine TCM usersc
 Excluding late TCM users (n = 67,604) 0.48 (0.47–0.49) ***
 Excluding former TCM users
  Cumulative duration ≥30 days (n = 51,568) 0.40 (0.39–0.42) ***
  Cumulative duration ≥60 days (n = 41,974) 0.37 (0.36–0.39) ***
  Cumulative duration ≥90 days (n = 35,252) 0.35 (0.33–0.36) ***
  1. *Significance: *p-value <.05; **p-value <.01; ***p-value <.001
  2. aThe same covariates, including age, gender, geolocation, insured level, comorbidities, medications, and previous experience with TCM were adjusted in every model
  3. bonly excluding renal transplantation patients and missing values
  4. cTCM users were redefined as followings: all TCM users except patients who initiated TCM treatment 6 months before death/end of follow-up (late TCM users), or patients who used TCM longer than 30, 60, or 90 days. PSM was used to select baseline characteristics-matched cohorts